136 related articles for article (PubMed ID: 24807638)
1. The expression of succinate dehydrogenase in breast phyllodes tumor.
Choi J; Kim DH; Jung W; Koo JS
Histol Histopathol; 2014 Oct; 29(10):1343-54. PubMed ID: 24807638
[TBL] [Abstract][Full Text] [Related]
2. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
4. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
6. Expression of lipid metabolism-related proteins in breast phyllodes tumors.
Jung YY; Lee YK; Koo JS
Neoplasma; 2016; 63(2):254-62. PubMed ID: 26774147
[TBL] [Abstract][Full Text] [Related]
7. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
[TBL] [Abstract][Full Text] [Related]
8. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
10. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
11. Expression of serine and glycine-related enzymes in phyllodes tumor.
Kwon JE; Kim DH; Jung WH; Koo JS
Neoplasma; 2014; 61(5):566-78. PubMed ID: 25030440
[TBL] [Abstract][Full Text] [Related]
12. Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.
Kim HM; Lee YK; Koo JS
Dis Markers; 2016; 2016():4218989. PubMed ID: 27881889
[No Abstract] [Full Text] [Related]
13. Succinate dehydrogenase expression in breast cancer.
Kim S; Kim DH; Jung WH; Koo JS
Springerplus; 2013 Dec; 2(1):299. PubMed ID: 23888270
[TBL] [Abstract][Full Text] [Related]
14. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
[TBL] [Abstract][Full Text] [Related]
15. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
Cha YJ; Koo JS
PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
Park S; Kang SY; Kwon GY; Kwon JE; Kim SK; Kim JY; Kim CH; Kim HJ; Moon KC; Pyo JY; Park WY; Park ES; Sung JY; Sung SH; Oh YH; Lee SE; Lee W; Lee JI; Cho NH; Jung SJ; Cho MS; Cho YM; Cho HY; Cha EJ; Chae YS; Choe G; Choi YJ; Huh J; Ro JY
Arch Pathol Lab Med; 2017 May; 141(5):671-677. PubMed ID: 27819762
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
Feakins RM; Wells CA; Young KA; Sheaff MT
Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
[TBL] [Abstract][Full Text] [Related]
18. Expression of Yes-associated protein (YAP) in breast phyllodes tumor.
Kim SK; Jung WH; Koo JS
Int J Clin Exp Pathol; 2014; 7(9):5997-6005. PubMed ID: 25337244
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
Tan WJ; Thike AA; Bay BH; Tan PH
Histopathology; 2014 May; 64(6):807-17. PubMed ID: 24438019
[TBL] [Abstract][Full Text] [Related]
20. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis.
Kwon JE; Jung WH; Koo JS
Tumour Biol; 2012 Jun; 33(3):787-98. PubMed ID: 22203494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]